AC Immune SA

IPO

AC Immune SA is a biotech company in Lausanne, Switzerland, founded in 2003. It has raised $100.1M across 4 rounds, most recently a Private Equity in December 2016.

Precision medicine for neurodegenerative diseases

Headquarters
Lausanne
Employees
51–200
Founded
2003
Business Model
B2B
Total Funding
$100.1M
Last Round
Private EquityDec 2016
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

AC Immune is a clinical-stage biopharmaceutical company emerging as a global leader in precision medicine to diagnose, treat and prevent neurodegenerative diseases. Since AC Immune's foundation in 2003, its staff has developed pioneering scientific and clinical expertise in the understanding and treatment of neurodegeneration. Its cutting-edge technology platforms, SupraAntigen and Morphomer, are the engines for a diverse pipeline of clinical and preclinical product candidates, with scientific excellence validated through collaborations with Takeda, Janssen, Life Molecular Imaging and Lilly.

Summary

It lists 51–200 employees. It has raised $100.1M in total across 4 rounds, most recently a Private Equity round in Dec 2016. Investors include Goldman Sachs, Morgan Stanley and SVB Leerink.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Private EquityPrivate EquityDec 2016

Sign up to see all 5 events

Funding: Series C through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AC Immune SA on Indexed.vc
<a href="https://indexed.vc/companies/ac-immune-sa"><img src="https://indexed.vc/api/badge/company/ac-immune-sa" alt="AC Immune SA on Indexed.vc" width="260" height="76" /></a>